Treatment of primary CNS lymphoma (PCNSL) following successful treatment of systemic non-Hodgkin's lymphoma (NHL): a case series

By Chamberlain Marc  

Journal of Neuro-Oncology, Vol. 113, Iss. 1, 2013-05 ,pp. : 27-32

Springer Publishing Company

Access to resources Recommend Favorite

Treatment-induced leukoencephalopathy in primary CNS lymphoma presenting as lower body parkinsonism

By Milia Antonio   Pilia Giuseppina   Mascia Maria   Manconi Francesco  

Journal of Neuro-Oncology, Vol. 100, Iss. 2, 2010-11 ,pp. : 281-283

Springer Publishing Company

Access to resources Recommend Favorite

Neurologic complications after intrathecal liposomal cytarabine in combination with systemic polychemotherapy in primary CNS lymphoma

By Ostermann Kathrin   Pels Hendrik   Kowoll Annika   Kuhnhenn Jan   Schlegel Uwe  

Journal of Neuro-Oncology, Vol. 103, Iss. 3, 2011-07 ,pp. : 635-640

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic factors in 140 adult patients with non-Hodgkin's lymphoma with systemic central nervous system (CNS) involvement. A single centre analysis

By Hollender A.   Kvaloy S.   Lote K.   Nome O.   Holte H.  

European Journal of Cancer, Vol. 36, Iss. 14, 2000-09 ,pp. : 1762-1768

Elsevier

Access to resources Recommend Favorite

Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study

By Pels Hendrik   Juergens Annika   Glasmacher Axel   Schulz Holger   Engert Andreas   Linnebank Michael   Schackert Gabriele   Reichmann Heinz   Kroschinsky Frank   Vogt-Schaden Marlies   Egerer Gerlinde   Bode Udo   Schaller Carlo   Lamprecht Monika   Hau Peter   Deckert Martina   Fimmers Rolf   Bangard Christopher   Schmidt-Wolf Ingo   Schlegel Uwe  

Journal of Neuro-Oncology, Vol. 91, Iss. 3, 2009-02 ,pp. : 299-305

Springer Publishing Company

Access to resources Recommend Favorite